MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Amifampridine

Amifampridine 10mg tablets

Use with caution

Stability notes for Amifampridine 10mg tablets

Protect from light and moisture. Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products, Firdapse 10mg tablets (SERB) and amifampridine phosphate 10mg tablets (Lupin Healthcare UK Ltd).

Supplier

Amifampridine 10mg tablets (Lupin Healthcare (UK) Ltd)

Amifampridine 20mg tablets

No stability information

Stability notes for Amifampridine 20mg tablets

There are no stability notes for this medicine.

Supplier

Amifampridine 20mg tablets (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.